BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 36973196)

  • 21. Renal cell carcinoma: the search for a reliable biomarker.
    Farber NJ; Kim CJ; Modi PK; Hon JD; Sadimin ET; Singer EA
    Transl Cancer Res; 2017 Jun; 6(3):620-632. PubMed ID: 28775935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial Intelligence-Based Non-invasive Differentiation of Distinct Histologic Subtypes of Renal Tumors With Multiphasic Multidetector Computed Tomography.
    Myers MR; Ravipati C; Thangam V
    Cureus; 2024 Apr; 16(4):e57959. PubMed ID: 38738077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A young female patient with multiple unilateral low-grade oncocytic renal tumors and angiomyolipoma: a case report and literature review.
    Xu Y; Jiang X; Meng H
    J Surg Case Rep; 2024 Mar; 2024(3):rjae125. PubMed ID: 38524677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of kidney cancer diagnosis and histological subtype within Canadian cancer registry data.
    Himmelman JG; Merrimen J; Matheson K; Theriault C; Wood LA
    Can Urol Assoc J; 2017 Sep; 11(9):E326-E329. PubMed ID: 29382453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of
    Ovruchesky E; Pan E; Guer M; Elliott A; Siva S; Ravi P; McGregor B; Bagrodia A; Derweesh I; Barata P; Heath EI; Antonarakis ES; Darabi S; Hoon DSB; Mortazavi A; Choueiri TK; Nabhan C; Wei S; McKay RR
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low grade oncocytic renal tumor: A case report.
    Zhang M; Tian H; Wang Q; Xing C
    Asian J Surg; 2024 May; ():. PubMed ID: 38806358
    [No Abstract]   [Full Text] [Related]  

  • 27. Eosinophilic solid and cystic renal cell carcinoma: A case report and literature review.
    Yang X; Wang Y; Zhang S; Zhang Z
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38493038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eosinophilic, solid, and cystic renal cell carcinoma (ESC-RCC)].
    Hartmann A; Agaimy A
    Pathologe; 2021 Nov; 42(6):565-570. PubMed ID: 34550432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
    Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
    [No Abstract]   [Full Text] [Related]  

  • 31. GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
    Salles DC; Asrani K; Woo J; Vidotto T; Liu HB; Vidal I; Matoso A; Netto GJ; Argani P; Lotan TL
    J Pathol; 2022 Jun; 257(2):158-171. PubMed ID: 35072947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
    Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J; Yang X; Zhou L; Zhang P; Wang C
    Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.